NEUROTECHNOLOGY, UAB - financials and debts

Company age: 35 y. 7 mo.

Update

NEUROTECHNOLOGY - Company finances

EUR
2018
From: 2018-01-01
To: 2018-12-31
2019
From: 2019-01-01
To: 2019-12-31
2020
From: 2020-01-01
To: 2020-12-31
2021
From: 2021-01-01
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-31
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 6,102,942 6,750,613 11,101,989 7,222,787 7,516,336 10,197,934 8,876,137 9,530,768
Profit before tax 504,378 486,603 3,216,750 -142,177 261,846 118,557 366,825 -222,212
Net profit 504,378 486,603 3,216,750 -142,177 261,846 118,557 366,825 -222,212
Equity 1,790,538 1,971,261 5,129,184 4,669,360 4,860,618 4,737,409 4,957,176 4,625,553
Liabilities 541,883 580,560 1,909,778 2,506,993 2,251,109 1,869,611 2,031,950 870,714
Non-current assets 849,240 1,231,501 2,664,023 2,754,915 2,850,602 3,154,421 3,136,978 3,128,619
Current assets 1,369,827 1,195,396 4,241,558 2,948,913 1,752,761 3,297,934 3,309,713 2,309,806
Total assets 2,219,067 2,426,897 6,905,581 5,703,828 4,603,363 6,452,355 6,446,691 5,438,425
Taxes paid
STI taxes - - - - - 1,318,813 1,317,185 1,662,349
Social insurance contributions - - - - - 1,598,233 1,443,301 1,628,458
Financial indicators
Revenue change y/y +35.0% +10.6% +64.5% -34.9% +4.1% +35.7% -13.0% +7.4%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. 22.7% 20.1% 46.6% -2.5% 5.7% 1.8% 5.7% -4.1%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. 28.2% 24.7% 62.7% -3.0% 5.4% 2.5% 7.4% -4.8%
Profit margin Net profit margin. Shows the overall profitability of the company. 8.3% 7.2% 29.0% -2.0% 3.5% 1.2% 4.1% -2.3%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. 8.3% 7.2% 29.0% -2.0% 3.5% 1.2% 4.1% -2.3%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. 0.3 0.3 0.4 0.5 0.5 0.4 0.4 0.2
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. 74,426 69,534 105,986 70,011 66,175 91,053 77,634 84,718

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

NEUROTECHNOLOGY - Social security debts

From To Debt, €
2024-12-17 2024-12-17 14818.83
2023-03-20 2023-04-10 0.09
2023-03-16 2023-03-19 210.09

NEUROTECHNOLOGY - VMI tax arrears

The company had no tax arrears (debts) to the State Tax Inspectorate

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
NEUROTECHNOLOGY, UAB (code 120441850) is a Private Limited Liability Company engaged in other computer programming activities. In the latest financial year, 2025, the company generated revenue of €9.53M, up 7.4% year on year, after €8.88M in 2024 and €10.20M in 2023. Profitability weakened in 2025, as net profit turned to a loss of €222.2K, compared with a profit of €366.8K in 2024 and €118.6K in 2023. The profit margin therefore declined to -2.3%. Over the three-year period, revenue remained broadly in the same range, but earnings showed a more volatile trend, moving from a modest profit to a stronger profit and then to a loss. As of 2025, total assets were €5.44M, equity €4.63M and liabilities €870.7K. The balance sheet remained equity-funded, with an equity ratio of 85.0% and debt-to-equity of 0.19. Asset turnover stood at 1.75x, ROE at -4.8% and ROA at -4.1%. Revenue per employee was €85.1K, while profit per employee was -€2.0K.